Boston Scientific's defib woes boost St. Jude Medical's Q1 results
April 21, 2010 by MedCity News
First-quarter sales for St. Jude Medical Inc. got a boost from Boston Scientific Corp.'s shutdown of its defibrillator operations, with STJ officials estimating an up to $25 million sales gain from its competitor's problems.
By Thomas Lee
There’s no love lost between St. Jude Medical Inc. (NYSE:STJ) and Boston Scientific Corp. (NYSE:BSX). The two rivals have clashed over sales and salespeople.
So it’s no surprise that St. Jude officials invented a special phrase to describe its competitor’s most recent regulatory woes: “the Boston Debacle.”
Business/Financial News, News Well, Cardiac Rhythm Management, Cardiovascular, MassDevice Earnings Roundup, Q1
Similar entries
- Show full page
- Login to post comments
-
Permalink
FDA Database Search
RECENT BLOG POSTS
- Funding R&D: High prices, overuse a failed strategy
- FDA's role in promoting women's health
- New partnership to boost use of GMDN codes for medical devices
- FDA's modern "Corps of Discovery" in China
- Consumers lose in latest FDA user fee bill; COI restraints disappear
- Gamification
- Cool technology of the week
- A new day: Interim thoughts on the 2012 Heart Rhythm Society scientific sessions
- When a child loses milestones, consider sleep EEG studies
- Red or blue pill for payment reform? Both won't work
NEWS
EuroPCR: Warnings on TAVI in replacing surgically implanted prosthetic valves
Transcatheter aortic valve implantation proves successful in reinforcing failed valve prosthetics,...
Weight loss: Surgery triggers rare metabolic wasting disease | MassDevice.com On Call
A rare but deadly genetic mutation that prevents the body from absorbing protein can be set off by...
Medical device tax: Ohio's industry pushes repeal while GOP group gets hyper-political
Ohio-based medical device makers meet with local legislators to discuss efforts to repeal the...
MassDevice.com +3 | The top 3 med-tech stories for May 15, 2012.
Boston Scientific's Lotus TAVI system minimizes leakage in an early trial, St. Jude Medical gains on...
Electromed CEO Robert Hansen retires after 20 years at the helm | Personnel Moves
Electromed founder, chairman & CEO Robert Hansen announces his retirement after 20 years leading...
